Presentation by Philipp Marchand and Birgitte Bieler, Vossius & Partner at the DayOne Expert Event Legal challenges and opportunities for digital health innovation
Philipp Marchand from Vossius & Partner and co-host of the event said: “Technological developments, especially in the digital space, brought up completely new issues which lack clear definition. So, as lawyers and regulatory advisers, we have to be innovative and also come up with new solutions. This is a learning curve we have to go through together with entrepreneurs, industry and regulatory bodies“.
In other words, instead of being a French garden à la Versaille, the legal landscape has become a rather rough terrain to navigate. The uncertainty can be seen as a threat and show killer. A more entrepreneurial attitude, however, would be to see it as an opportunity, if not an invitation, to pursue more of a greenfield approach. But in order to make this happen, it is essential to address the legal aspects early on and make them part of the solution.
Protection
Accustomaed as it is to a science and engineering-driven approach, the healthcare industry has to change its mindset when it comes to protecting its business. As it is reasonable to patent a digital solution and to protect medical devices as well as mobile app interfaces by means of design and trademark rights, the legal framework is becoming more important. So, developing a great technological solution and then having it beautified later on will not suffice. Those capabilities have to be built in from day one to ensure freedom to operate and to generate added value from the digital solutions.
Legal Framework for Digital Health Innovation - Data Protection and SecurityDayOne
Presentation by Monika Menz, Vossius & Partner at the DayOne Expert Event Legal challenges and opportunities for digital health innovation.
Data - GDPR still governs the data protection landscape and is here to stay. But GDPR is more than an implementation issue – innovators need to embrace its principles already when designing their products, not only to be compliant but also to gain the trust of customers and patients. As healthcare innovations are IT dependent and data driven, data and IT security are often neglected. But they are key to convincing investors and customers of the innovator’s business model, because the stakes are high, not only in terms of a start-up’s reputation and liability, but ultimately and most of all in terms of the patient’s interests as well.
Presentation delivered at the RMD 2016 conference (European Symposium on the New Agreed Draft Regulations on Medical Devices) in Prague on 7 November 2016
Use of left over samples under the IVDR and GDPRErik Vollebregt
Presentation on the RAPS Convergence 2017 about the use of left over samples in performance evaluation under the In Vitro Diagnostics Regulation (IVDR) and under the General Data Protection Regulation (GDPR)
Presentation about transparency under the new MDR and IVDR at Informa Medtech Summit in Clinical evaluations and investigations for medical devices track
Legal Framework for Digital Health Innovation - Data Protection and SecurityDayOne
Presentation by Monika Menz, Vossius & Partner at the DayOne Expert Event Legal challenges and opportunities for digital health innovation.
Data - GDPR still governs the data protection landscape and is here to stay. But GDPR is more than an implementation issue – innovators need to embrace its principles already when designing their products, not only to be compliant but also to gain the trust of customers and patients. As healthcare innovations are IT dependent and data driven, data and IT security are often neglected. But they are key to convincing investors and customers of the innovator’s business model, because the stakes are high, not only in terms of a start-up’s reputation and liability, but ultimately and most of all in terms of the patient’s interests as well.
Presentation delivered at the RMD 2016 conference (European Symposium on the New Agreed Draft Regulations on Medical Devices) in Prague on 7 November 2016
Use of left over samples under the IVDR and GDPRErik Vollebregt
Presentation on the RAPS Convergence 2017 about the use of left over samples in performance evaluation under the In Vitro Diagnostics Regulation (IVDR) and under the General Data Protection Regulation (GDPR)
Presentation about transparency under the new MDR and IVDR at Informa Medtech Summit in Clinical evaluations and investigations for medical devices track
'Connected healthcare - connected to legality?'Lucy Woods
In January 2016, we held a Legal SIG (special interest group) at the London HQ of Olswang. Speakers included Juma El-Awaisi of Braci, Ross McKean of Olswang and Ken Munro of Pen Test Partners. Ken's presentation was interactive so slides are coming soon!
Are blockchain and EU-GDPR compatible? This presentation from 2020, from Dennis Hillemann (Podcast: The Blockchain lawyer), explains the most important legal challenges. The presentation explains:
- What are basic principles of GDPR?
- What are basic functionalities of the blockchain technology?
- What main issues are there between GDPR and blockchain technology?
- What is personal data in a blockchain scenario?
- Personal data & encryption and & hashing
- Salting and Peppering
- Data processor and controller in a blockchain scneario
- Right to rectification and right to erasure
- Transfer to third countries
- National and internatinal activities to bring Blockchain and GDPR together.
From 25 May 2018 all public bodies must have a Data Protection Officer (DPO). The DPO must have ‘expert’ knowledge of both data protection law and practice. This session is directed at individuals within public sector organisations who will be acting as DPO, their deputies and those advising them.
Visit our website for more useful resources - https://www.brownejacobson.com/sectors-and-services/sectors/public-sector
GDPR for public sector DPO's seminar, April 2018, ManchesterBrowne Jacobson LLP
From 25 May 2018 all public bodies must have a Data Protection Officer (DPO). The DPO must have ‘expert’ knowledge of both data protection law and practice. This session is directed at individuals within public sector organisations who will be acting as DPO, their deputies and those advising them.
Visit our website for more useful resources - https://www.brownejacobson.com/sectors-and-services/sectors/public-sector
Draft Bill on the Protection of Personal DataRenato Monteiro
Presentation given at the DataGuidance´s webinar "Brazil: Towards Privacy Compliance", about the Brazlian Draft Bill for the Protection of Personal Data (Anteprojeto de Lei para a Proteção de Dados Pessoais) issued in January 2015, which introduced concepts such as Data Protection Officer and Binding Corporate Rules.
From 25 May 2018 all public bodies must have a Data Protection Officer (DPO). The DPO must have ‘expert’ knowledge of both data protection law and practice. This session is directed at individuals within public sector organisations who will be acting as DPO, their deputies and those advising them.
Visit our website for more useful resources - https://www.brownejacobson.com/sectors-and-services/sectors/public-sector
GDPR clinic - A strategic approach for compliance with the European General Data Protection regulation
Paolo Balboni Ph.D. - Founding Partner at ICT Legal Consulting & President of the European Privacy Association
Nicola Franchetto LL.M. - Associate at ICT Legal Consulting &
Fellow of the European Privacy Association
Beyond Privacy: Learning Data Ethics - European Big Data Community Forum 2019...IDC4EU
This is the slide-deck of the community event held on November 14, 2019 in Brussels, titled "Beyond Privacy: Learning Data Ethics - European Big Data Community Forum 2019". It includes the presentations given by the speakers.
The Court Speaks: Privacy Shield, Standard Contractual Clauses and Cookie Con...TrustArc
There are some interesting developments in the world of case law. With so much focus on the CCPA enforcement date implications, many may have forgotten about the forthcoming decision in the Schrems II case, which could decide the fate of the Standard Contractual Clauses and the Privacy Shield for data transfers from Europe to the United States and elsewhere.
At the same time, the European Commission is working on the evaluation of all EU adequacy decisions and encouraging various countries to update their data protection laws. As to cookies, the Planet-49 case last year put clear boundaries around the issue of cookie consent. What has happened with this ruling of the European Court of Justice and how does it impact cookie compliance around the world?
Join us as we discuss the various international cross-border data transfer updates and how to navigate the potential significant changes.
This webinar will review:
-Implications of the Schrems II case decision
-The status of Privacy Shield and next steps
-European Commission adequacy re-assessment
-EDPB Guidelines on Consent and the revised IAB Framework updates
"Towards Value-Centric Big Data" e-SIDES Workshop - "Safe and secure data mar...e-SIDES.eu
The following presentation was given by Alessandro Bruni, Legal Researcher at KU Leuven, during the e-SIDES workshop "Towards Value-Centric Big Data" held on April 2, 2019 in Brussels.
"Towards Value-Centric Big Data" e-SIDES Workshop - Slide-decke-SIDES.eu
This is the slide-deck of the workshop held at the BDV Meet-UP on June 27, 2019 in Riga, titled "Towards Value-Centric Big Data". It includes the presentations given by the speakers.
'Connected healthcare - connected to legality?'Lucy Woods
In January 2016, we held a Legal SIG (special interest group) at the London HQ of Olswang. Speakers included Juma El-Awaisi of Braci, Ross McKean of Olswang and Ken Munro of Pen Test Partners. Ken's presentation was interactive so slides are coming soon!
Are blockchain and EU-GDPR compatible? This presentation from 2020, from Dennis Hillemann (Podcast: The Blockchain lawyer), explains the most important legal challenges. The presentation explains:
- What are basic principles of GDPR?
- What are basic functionalities of the blockchain technology?
- What main issues are there between GDPR and blockchain technology?
- What is personal data in a blockchain scenario?
- Personal data & encryption and & hashing
- Salting and Peppering
- Data processor and controller in a blockchain scneario
- Right to rectification and right to erasure
- Transfer to third countries
- National and internatinal activities to bring Blockchain and GDPR together.
From 25 May 2018 all public bodies must have a Data Protection Officer (DPO). The DPO must have ‘expert’ knowledge of both data protection law and practice. This session is directed at individuals within public sector organisations who will be acting as DPO, their deputies and those advising them.
Visit our website for more useful resources - https://www.brownejacobson.com/sectors-and-services/sectors/public-sector
GDPR for public sector DPO's seminar, April 2018, ManchesterBrowne Jacobson LLP
From 25 May 2018 all public bodies must have a Data Protection Officer (DPO). The DPO must have ‘expert’ knowledge of both data protection law and practice. This session is directed at individuals within public sector organisations who will be acting as DPO, their deputies and those advising them.
Visit our website for more useful resources - https://www.brownejacobson.com/sectors-and-services/sectors/public-sector
Draft Bill on the Protection of Personal DataRenato Monteiro
Presentation given at the DataGuidance´s webinar "Brazil: Towards Privacy Compliance", about the Brazlian Draft Bill for the Protection of Personal Data (Anteprojeto de Lei para a Proteção de Dados Pessoais) issued in January 2015, which introduced concepts such as Data Protection Officer and Binding Corporate Rules.
From 25 May 2018 all public bodies must have a Data Protection Officer (DPO). The DPO must have ‘expert’ knowledge of both data protection law and practice. This session is directed at individuals within public sector organisations who will be acting as DPO, their deputies and those advising them.
Visit our website for more useful resources - https://www.brownejacobson.com/sectors-and-services/sectors/public-sector
GDPR clinic - A strategic approach for compliance with the European General Data Protection regulation
Paolo Balboni Ph.D. - Founding Partner at ICT Legal Consulting & President of the European Privacy Association
Nicola Franchetto LL.M. - Associate at ICT Legal Consulting &
Fellow of the European Privacy Association
Beyond Privacy: Learning Data Ethics - European Big Data Community Forum 2019...IDC4EU
This is the slide-deck of the community event held on November 14, 2019 in Brussels, titled "Beyond Privacy: Learning Data Ethics - European Big Data Community Forum 2019". It includes the presentations given by the speakers.
The Court Speaks: Privacy Shield, Standard Contractual Clauses and Cookie Con...TrustArc
There are some interesting developments in the world of case law. With so much focus on the CCPA enforcement date implications, many may have forgotten about the forthcoming decision in the Schrems II case, which could decide the fate of the Standard Contractual Clauses and the Privacy Shield for data transfers from Europe to the United States and elsewhere.
At the same time, the European Commission is working on the evaluation of all EU adequacy decisions and encouraging various countries to update their data protection laws. As to cookies, the Planet-49 case last year put clear boundaries around the issue of cookie consent. What has happened with this ruling of the European Court of Justice and how does it impact cookie compliance around the world?
Join us as we discuss the various international cross-border data transfer updates and how to navigate the potential significant changes.
This webinar will review:
-Implications of the Schrems II case decision
-The status of Privacy Shield and next steps
-European Commission adequacy re-assessment
-EDPB Guidelines on Consent and the revised IAB Framework updates
"Towards Value-Centric Big Data" e-SIDES Workshop - "Safe and secure data mar...e-SIDES.eu
The following presentation was given by Alessandro Bruni, Legal Researcher at KU Leuven, during the e-SIDES workshop "Towards Value-Centric Big Data" held on April 2, 2019 in Brussels.
"Towards Value-Centric Big Data" e-SIDES Workshop - Slide-decke-SIDES.eu
This is the slide-deck of the workshop held at the BDV Meet-UP on June 27, 2019 in Riga, titled "Towards Value-Centric Big Data". It includes the presentations given by the speakers.
The Role of Intellectual Property Rights for the Growth of ICT Industry in Be...Patterson Thuente IP
IP protection for computer-related inventions - The Problem: early history and early efforts.
Current legislative framework - USA, Europe, India.
Current situation - USA, Europe, India.
Tips and best practices.
Brief mention of other topics.
"Data Breaches & the Upcoming Data Protection Legal Framework: What’s the Buz...Cédric Laurant
Cédric Laurant: Presentation at the SecureWorld Web Conference: "Incident Response: Clean Up on Aisle Nine" (29 Nov. 2012)
Presentation can be downloaded at http://cedriclaurant.com/about/presentations/, http://blog.cedriclaurant.org and http://security-breaches.com.
Riccardo Vieri has filed for patents to protect the specific inventions including Systems, Methods or Techniques for Providing Advertisements, Coupons or Discount to Devices, Auctioning System and Methods Interacting with Multiple Devices, System to Generate and Set up an Advertising Campaign based on the Insertion of Advertising Messages within an Exchange of Messages, and Method to Operate Said System and many more.
An invention is protected under the Law on Patents, Utility Model Certificates and Industrial Designs dated 22 January 2003 (“Cambodia Patent Law”). The procedures for the grant of Patents and Utility Model Certificates are detailed in Cambodia Prakas (Declaration) No. 766 MIME.DIP.PRK dated 28 May 2007.
An invention is defined as “the idea of an inventor which permits in practice the solution to a specific problem in the field of technology”. The Cambodia Patent Law further clarifies that an invention may either be, or relate to, both a product and a process
The autonomy of decision-making of Artificial Intelligence (AI) technology products, opens the discussion on multiple ethical and legal issues, that aim to find a solution on how to regulate AI defective product liability, social risk and consumers’ safety.
If the debate on the legal qualification of such products, in particular intelligent robots, is still far away from finding a common answer, the problem of products’ liability has been partly solved by adapting the already existing rules on manufacturers liability to AI algorithm’s developers.
Due to various inadequacies showed by this kind of approach, such as incompatibilities between the definitions of machine learning algorithm and manufactured product, the European Commission has targeted this issues, providing hypothetical different solutions that may pursue a new legal scheme able to increase social confidence in AI technology and enlarge the sample of potential investors.
Robotics & Artificial (RAI) Intelligence webinar: Law & Regulation for RAI In...KTN
The Robotics & AI Innovation Network hosted a webinar addressing some of the legal and regulatory issues faced by the RAI community in the UK. Three legal experts provided their expertise to address these issues.
- Doug Bryden | Partner; Head of the Operational Risk & Environment Group, Travers Smith LLP
- Mark Richardson | Partner; IT, Telecoms and Electronics, Keltie
- Sébastien A. Krier | Founder & AI Ethics/Policy Expert, Dataphysix Ltd
Big Data lay at the core of the strong data economy that is emerging in Europe. Although both large enterprises and SMEs acknowledge the potential of Big Data in disrupting the market and business models, this is not reflected in the growth of the data economy. The lack of trusted, secure, ethical-driven personal data platforms and privacy-aware analytics, hinders the growth of the data economy and creates concerns. The main considerations are related to the secure sharing of personal and proprietary/industrial data, and the definition of a fair remuneration mechanism that will be able to capture, produce, release and cash out the value of data, always for the benefit of all the involved stakeholders.
This webinar will focus on how such concerns that pertain to privacy, ethics and intellectual property rights can be tackled, by allowing individuals to take ownership and control of their data and share them at will, through flexible data sharing and fair compensation schemes with other entities (companies or not), as researched by the DataVaults project.
Understanding the health data future - Deloitte Healthconnect, co-hosted by D...DayOne
In collaboration with Deloitte, we launched in 2020 the DayOne Health Data Scenario Project. Some 50 Experts coming together in three workshops for a total of more than 18 hours have identified 10 potential scenarios that will lead the way in creating a much-needed efficient and rewarding healthcare data ecosystem. We presented our results in an online joint event: “Understanding the health data future – Deloitte Healthconnect, co-hosted by DayOne”
“It’s cheaper to clean up a mess than to avoid a mess.” This mantra, coined by Alan Greenspan explaining why financial bubbles happen, stands very much at the core of how we as a society typically seem to deal with health: rather than nudging and rewarding people to conduct a healthier life and increase their immunity, the primary focus of efforts and resources is often on treating sickness.
How can this change? What role do health data, nutrition and immunity play in this? And what difference would it make? Find out at our next DayOne Experts Event, co-hosted by DSM Nutritional Products.
There are a couple of reasons why it is not an easy thing to successfully implement preventive measures. First of all, behavioral change is hard to accomplish. Secondly, in most cases it is challenging to show the scientific evidence that a certain measure works and is worth the effort. One key focus area is the importance of an optimal nutrient intake to support our health – with a focus on immunity and beyond. Last but not least, we need to consider a business and policy model that makes prevention less of a moral burden but a worthwhile experience that we are willing to apply in a smart way.
These are the big questions we will address at the DayOne Experts Event:
Will the rise of digital and data availability change the landscape – and if so to what extent?
What can we learn from the current pandemic?
Does nutrition play a role in supporting your immunity?
Which data should we take into consideration to shape the future?
This was our conversation. Read the conclusions here: https://www.dayone.swiss/as-shown-by-covid-19-making-prevention-smart-requires-a-mind-shift/
Our partner: DSM Nutritional Products
For the 5th year, we culminated the best of the DayOne Healthcare Innovation initiative: hot topics, open debates, smart insights, bright ideas, high energy personalities and tangible expertise. This will include the Open Innovation Session that brings together the Health Hack and is a springboard for the Accelerator. The panel sessions included: The patient centric approach + four bright ideas; How to make it happen; + The healthcare innovation journey.
This year’s conference joined forces with BioData Congress 2020 in a virtual format. Thank you to the partners Arcondis and Innosuisse, as well as all the mentors, coaches and behind the scenes work to pull this all together in a great event wtih over 800 participants.
Breathe - Empowering parents of children with asthmaDayOne
Presentation by Moritz Dietsche (Haako) at the DayOne Expert Event Legal challenges and opportunities for digital health innovation.
it is essential to address the legal aspects early on and make them part of the solution. This was shown by this start-up showcase:
Pioneering value & data driven healthcare for PatientsDayOne
Presentation by Michel Mohler (Lyfegen) at the DayOne Expert Event Legal challenges and opportunities for digital health innovation.
it is essential to address the legal aspects early on and make them part of the solution. This was shown by this start-up showcase:
EU regulatory frameworks - Legal challenges and opportunities for digital hea...DayOne
Presentation by Karin Schulze, Head of Medical Devices at SFL at the DayOne Expert Event Legal challenges and opportunities for digital health innovation
Regulation
Regarding the new MDR, the big question that arises is not only whether a piece of software falls under the definition of a medical device, but also who decides whether it does. At least in this regard the new regulation is clear: it is the regulator. Which means, according to Karin Shulze from SFL, that If a company offers an app which they do not consider a medical device themselves, but the regulator does, the distribution of this app will be stopped.
Expert Event Legal challenges and opportunities for digital health innovationDayOne
Introduction by Thomas Brenzikofer, DayOne, Basel Area Business & Innovation
Greenfield or jungle? Navigating the legal landscape for digital healthcare innovation
At first sight, it’s hard not to agree that dealing with the legal aspects of creating healthcare innovation is — although necessary — a rather unsexy topic. So it comes as no surprise that the DayOne Experts Event “Legal challenges and opportunities for healthcare innovation”, held online on September 30, attracted a slightly smaller audience than when the talks usually concern revolutionary new pieces of digital technology ready to disrupt healthcare as we know it — for the better.
Future of aging day one 20200630 zaynakhayatDayOne
What comes to mind when you think of an older person? Who are they? Where do they live? What does their day look like? How do they want to live their life, make money, spend money, experience services and leave a legacy?
These are just some among the many provocative questions that were researched in the new book “The Future of Aging” by Zayna Khayat. The book provides a much needed «reboot» of the perspective on how society needs to engage with the aging population. It is also a reminder of the limits to current approaches to aging. The vision Zayna Khayat proposes is intended to help individuals and organizations of all types and from all sectors position themselves as long-term partners on whom aging adults can depend as they navigate their experiences of aging.
Innovation for the future of aging will include new policies, services, products, technologies, living spaces, and even approaches to shaping inter-generational communities—all of which will be transformative for the lives of older adults. The potential societal and economic returns from innovation for the future of aging are immense, and therefore need to be prioritized.
It’s time to redefine what it means to age.
We are proud to host Zayna Khayat for the DayOne LabTalk to discuss innovation opportunities for the future of aging!
This event is part of our Aging Well Catalyst project by DayOne: a journey which will seek out innovative solutions that can help with both functional and psycho-social well-being. Learn more at Dayone.swiss
Value-based Healthcare - Towards a systems approach in chronic diseasesnDayOne
Role of patient journey in science, predictive modeling and high-risk patients in early stages of disease progression, in real world context. Presented by Michael Rebhan, Novartis at the DayOne Basel event in June 2020
Value-based Healthcare today and tomorrow by Deloitte.DayOne
There is an increasing need for a value-based Healthcare based on holistic patient and health system outcomes. Success can only be reached by a genuinely collaborative approach.
Presented at the DayOne Expert event in Basel
The slides in this deck are what were discussed in the first of five Aging Well workshops. This first workshop focused on mobility for aging adults. Take a look.
How can digital bridge the mental health gaps?
Mental health is a story of gaps. This was made clear by all the speakers and panelists at DayOne’s most recent Expert Meeting titled “Measuring the Unmeasurable - will digital pave the way for new treatments in mental health?” which took place in Basel. Check out the slides from the event here.
20191203 DOE Data Driven Healthcare- Expert EventDayOne
DayOne Experts - Data-driven healthcare – are we ready?
Data is transforming healthcare. Health data from multiple sources such as electronic health records, genomic testing, imaging and digital tools, combined with advanced analytics can be used to deliver more personalised care, improve outcomes, empower patients and make healthcare more sustainable and efficient. But is the industry ready for these new approaches? What is needed on the policy level and in the regulatory field to enable a new era of data driven health solutions? How will their business models look like?
This is what we discussed at this DayOne Expert Event, which was proudly presented in close collaboration with the Embassy of the Netherlands, fostering the exchange between two world leading healthcare innovation ecosystems.
Healthcare delivery in the periphery workshop outputDayOne
A tri-national (CH, D, F) group of healthcare and labor experts came together at the DayOne lab to brainstorm on common initiatives to tackle the challenges of Healthcare delivery in our region. Please find attached the output of our workshop here.
What does “patient centricity” really mean and how is it actually done? This was the driving question of the DayOne Experts Meeting in Basel, co-hosted by Arcondis.
Input speech to panel on ethics from Evelyne Bischof, Shanghai University of Medicine & Health Sciences University Hospital Basel at the DayOne Conference 2019 Shaping the future of Health September 9th 2019
Durrenmatt's Computer Scientists: Caught between moral and technological deve...DayOne
Input speech to panel on ethics from Bram Stieltjes, University Hospital Basel at the DayOne Conference 2019 Shaping the future of Health September 9th 2019
How many patients does case series should have In comparison to case reports.pdfpubrica101
Pubrica’s team of researchers and writers create scientific and medical research articles, which may be important resources for authors and practitioners. Pubrica medical writers assist you in creating and revising the introduction by alerting the reader to gaps in the chosen study subject. Our professionals understand the order in which the hypothesis topic is followed by the broad subject, the issue, and the backdrop.
https://pubrica.com/academy/case-study-or-series/how-many-patients-does-case-series-should-have-in-comparison-to-case-reports/
Empowering ACOs: Leveraging Quality Management Tools for MIPS and BeyondHealth Catalyst
Join us as we delve into the crucial realm of quality reporting for MSSP (Medicare Shared Savings Program) Accountable Care Organizations (ACOs).
In this session, we will explore how a robust quality management solution can empower your organization to meet regulatory requirements and improve processes for MIPS reporting and internal quality programs. Learn how our MeasureAble application enables compliance and fosters continuous improvement.
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...Dr. David Greene Arizona
As we watch Dr. Greene's continued efforts and research in Arizona, it's clear that stem cell therapy holds a promising key to unlocking new doors in the treatment of kidney disease. With each study and trial, we step closer to a world where kidney disease is no longer a life sentence but a treatable condition, thanks to pioneers like Dr. David Greene.
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdfSachin Sharma
Pediatric nurses play a vital role in the health and well-being of children. Their responsibilities are wide-ranging, and their objectives can be categorized into several key areas:
1. Direct Patient Care:
Objective: Provide comprehensive and compassionate care to infants, children, and adolescents in various healthcare settings (hospitals, clinics, etc.).
This includes tasks like:
Monitoring vital signs and physical condition.
Administering medications and treatments.
Performing procedures as directed by doctors.
Assisting with daily living activities (bathing, feeding).
Providing emotional support and pain management.
2. Health Promotion and Education:
Objective: Promote healthy behaviors and educate children, families, and communities about preventive healthcare.
This includes tasks like:
Administering vaccinations.
Providing education on nutrition, hygiene, and development.
Offering breastfeeding and childbirth support.
Counseling families on safety and injury prevention.
3. Collaboration and Advocacy:
Objective: Collaborate effectively with doctors, social workers, therapists, and other healthcare professionals to ensure coordinated care for children.
Objective: Advocate for the rights and best interests of their patients, especially when children cannot speak for themselves.
This includes tasks like:
Communicating effectively with healthcare teams.
Identifying and addressing potential risks to child welfare.
Educating families about their child's condition and treatment options.
4. Professional Development and Research:
Objective: Stay up-to-date on the latest advancements in pediatric healthcare through continuing education and research.
Objective: Contribute to improving the quality of care for children by participating in research initiatives.
This includes tasks like:
Attending workshops and conferences on pediatric nursing.
Participating in clinical trials related to child health.
Implementing evidence-based practices into their daily routines.
By fulfilling these objectives, pediatric nurses play a crucial role in ensuring the optimal health and well-being of children throughout all stages of their development.
Health Education on prevention of hypertensionRadhika kulvi
Hypertension is a chronic condition of concern due to its role in the causation of coronary heart diseases. Hypertension is a worldwide epidemic and important risk factor for coronary artery disease, stroke and renal diseases. Blood pressure is the force exerted by the blood against the walls of the blood vessels and is sufficient to maintain tissue perfusion during activity and rest. Hypertension is sustained elevation of BP. In adults, HTN exists when systolic blood pressure is equal to or greater than 140mmHg or diastolic BP is equal to or greater than 90mmHg. The
R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptxR3 Stem Cell
R3 Stem Cells and Kidney Repair: A New Horizon in Nephrology" explores groundbreaking advancements in the use of R3 stem cells for kidney disease treatment. This insightful piece delves into the potential of these cells to regenerate damaged kidney tissue, offering new hope for patients and reshaping the future of nephrology.
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...ILC- UK
The Healthy Ageing and Prevention Index is an online tool created by ILC that ranks countries on six metrics including, life span, health span, work span, income, environmental performance, and happiness. The Index helps us understand how well countries have adapted to longevity and inform decision makers on what must be done to maximise the economic benefits that comes with living well for longer.
Alongside the 77th World Health Assembly in Geneva on 28 May 2024, we launched the second version of our Index, allowing us to track progress and give new insights into what needs to be done to keep populations healthier for longer.
The speakers included:
Professor Orazio Schillaci, Minister of Health, Italy
Dr Hans Groth, Chairman of the Board, World Demographic & Ageing Forum
Professor Ilona Kickbusch, Founder and Chair, Global Health Centre, Geneva Graduate Institute and co-chair, World Health Summit Council
Dr Natasha Azzopardi Muscat, Director, Country Health Policies and Systems Division, World Health Organisation EURO
Dr Marta Lomazzi, Executive Manager, World Federation of Public Health Associations
Dr Shyam Bishen, Head, Centre for Health and Healthcare and Member of the Executive Committee, World Economic Forum
Dr Karin Tegmark Wisell, Director General, Public Health Agency of Sweden
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
The dimensions of healthcare quality refer to various attributes or aspects that define the standard of healthcare services. These dimensions are used to evaluate, measure, and improve the quality of care provided to patients. A comprehensive understanding of these dimensions ensures that healthcare systems can address various aspects of patient care effectively and holistically. Dimensions of Healthcare Quality and Performance of care include the following; Appropriateness, Availability, Competence, Continuity, Effectiveness, Efficiency, Efficacy, Prevention, Respect and Care, Safety as well as Timeliness.
CRISPR-Cas9, a revolutionary gene-editing tool, holds immense potential to reshape medicine, agriculture, and our understanding of life. But like any powerful tool, it comes with ethical considerations.
Unveiling CRISPR: This naturally occurring bacterial defense system (crRNA & Cas9 protein) fights viruses. Scientists repurposed it for precise gene editing (correction, deletion, insertion) by targeting specific DNA sequences.
The Promise: CRISPR offers exciting possibilities:
Gene Therapy: Correcting genetic diseases like cystic fibrosis.
Agriculture: Engineering crops resistant to pests and harsh environments.
Research: Studying gene function to unlock new knowledge.
The Peril: Ethical concerns demand attention:
Off-target Effects: Unintended DNA edits can have unforeseen consequences.
Eugenics: Misusing CRISPR for designer babies raises social and ethical questions.
Equity: High costs could limit access to this potentially life-saving technology.
The Path Forward: Responsible development is crucial:
International Collaboration: Clear guidelines are needed for research and human trials.
Public Education: Open discussions ensure informed decisions about CRISPR.
Prioritize Safety and Ethics: Safety and ethical principles must be paramount.
CRISPR offers a powerful tool for a better future, but responsible development and addressing ethical concerns are essential. By prioritizing safety, fostering open dialogue, and ensuring equitable access, we can harness CRISPR's power for the benefit of all. (2998 characters)